Bridgewater Chapter Upcoming Events Join PCCI

Actuated Medical Inc.

A medical devices company

Presenter: Maureen Mulvihill, PhD, President and CEO of AMI


Monday, March 12, 2012

Embassy Suites, Chesterbrook, Pennsylvania (directions)




Actuated Medical Inc (AMI) develops innovative medical devices and components that incorporate piezoelectric and other controlled motion technologies. Our business model is to take these innovations to a stage where we can sell or license them to firms with global sales and marketing capabilities. Because our products are developed under an ISO-certified quality control system, and we obtain FDA approvals, partner risk is substantially reduced. AMI also has the capacity to manufacture components or devices. Ultimately, our innovations allow clinicians to perform faster, easier, and safer procedures.


Tube-Clear: Declogging Tubes Easily and Effectively


Patients who are unable to swallow due to a condition ranging from Alzheimer's disease to traumatic injury often require tubes for nutrition, medication, or decompression. Whether surgically or non-surgically placed, these tubes can become obstructed, and there has been no easy and safe way to clear them–until now. Actuated Medical has developed a device that uses Innovative Motion™ to clear feeding and decompression tubes without removing them from the patient. Designed, tested, and manufactured under an ISO-certified quality control system, our Tube-Clear™ systems allow caregivers to minimize time spent on hardware issues and maximize time spent on caring for their patients.



3 Major Issues


  1. We are currently deciding between bringing in house the ability to manufacture at full volume (10,000 units per month) versus engaging a contract manufacturer (who would then need to cover their own overhead costs and profit).  What is the best way to decide between scale up or hand off?

  2. We have a potential distributor interested in the opportunity.  He said that he thinks we have something but is having trouble understanding the true market size or how the market will accept the device.  How do we quantitatively prove to distributors that this technology is a great opportunity? How do we establish a value proposition for him to take to his board?  What are example distribution scenarios (terms) used by others?

  3. There is not a code for clearing nasogastric feeding tubes. Tube-Clear saves nursing time, restores nutrition and medication regimen, minimizes legal risk of new tube mis-placement, eliminates the cost ($15) of a new tube and eliminates an x-ray confirmation of placement ($200).  There is no clear reimbursement path that we know about.  How do we determine reimbursement and ROI to a hospital system or third-party payor?  





6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)

8:00 - Maureen Mulvihill, PhD, President and CEO of AMI, will deliver the Company's "Elevator" Pitch to the Group

8:20 - A Panel will address 3 Major Issues for the Company

9:00 - Open discussion: members and guests



<Top of the page>




Available Media

Please note: All information obtained here is the property of those presenting and should not be copied or duplicated without written consent.



None available at this time


None available at this time


None available at this time


Actuated Medical Webcast - 03/12/12

Contact Info:





Questions or Coments?

Contact: Peter van der Kam, | (610) 296-8086




Good Company! Good Drink! Good Food! Good Program! Good Fun!


Site Navigation



Pharmaceutical Consulting Consortium International, Inc., or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2018



Tat Communication Inc